Skip to main content
. 2023 Mar 8;20(4):268–286. doi: 10.20892/j.issn.2095-3941.2022.0547

Figure 2.

Figure 2

Forest plot of hazard or odds ratio for clinical characteristics in each subgroup from different studies. Each subgroup used the underweight/normal weight group as a reference. FEC-DocG, 5-fluorouracil, epirubicin, cyclophosphamide - docetaxel, gemcitabine; FEC-Doc, 5-fluorouracil, epirubicin, cyclophosphamide - docetaxel; CI, confidence interval. According to the WHO criteria, patients are classified as underweight/normal weight (BMI < 25 kg/m2), overweight (BMI = 25–29.9 kg/m2), slightly obese (BMI = 30–34.9 kg/m2), moderately obese (BMI = 35.0–39.9 kg/m2), and severely obese (BMI ≥ 40.0 kg/m2).